Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Short term Debt (2018 - 2020)

Historic Short term Debt for ImmunoTech (AIM) over the last 6 years, with Q3 2020 value amounting to $226000.0.

  • ImmunoTech's Short term Debt fell 8920.21% to $226000.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $226000.0, marking a year-over-year decrease of 8920.21%. This contributed to the annual value of $214000.0 for FY2019, which is 753.77% up from last year.
  • Latest data reveals that ImmunoTech reported Short term Debt of $226000.0 as of Q3 2020, which was down 8920.21% from $221000.0 recorded in Q2 2020.
  • In the past 5 years, ImmunoTech's Short term Debt registered a high of $2.1 million during Q3 2019, and its lowest value of $195000.0 during Q2 2018.
  • Moreover, its 3-year median value for Short term Debt was $214000.0 (2019), whereas its average is $380909.1.
  • In the last 5 years, ImmunoTech's Short term Debt skyrocketed by 96243.65% in 2019 and then crashed by 8920.21% in 2020.
  • Quarter analysis of 3 years shows ImmunoTech's Short term Debt stood at $199000.0 in 2018, then rose by 7.54% to $214000.0 in 2019, then increased by 5.61% to $226000.0 in 2020.
  • Its last three reported values are $226000.0 in Q3 2020, $221000.0 for Q2 2020, and $217000.0 during Q1 2020.